Cannabis reclassification could 'open the floodgates' for research, scientists say
PositiveHealth
- President Donald Trump has signed an executive order to reclassify marijuana from a Schedule I drug to a Schedule III substance, marking a significant shift in U.S. drug policy aimed at facilitating medical research and easing federal restrictions on cannabis.
- This reclassification is expected to open new avenues for scientific research into the benefits and harms of marijuana, potentially leading to a better understanding of its medical applications and easing the tax burdens on cannabis businesses.
- The decision reflects a broader trend in U.S. drug policy towards more lenient regulations on cannabis, amidst ongoing debates about its medical use and the implications for public health and safety, as well as reactions from various political factions regarding the potential economic impact.
— via World Pulse Now AI Editorial System